Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$165M
-
Value change
-
+$8.8M
-
Number of buys
-
28
-
Number of sells
-
-16
-
Price
-
$6.21
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2018
58 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2018.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 237M outstanding shares and own 11.25% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.52M shares), Consonance Capital Management LP (4.54M shares), Broadfin Capital, LLC (4.46M shares), Aisling Capital LLC (3.61M shares), Biomark Capital Management Co. LLC (1.43M shares), Vanguard Group Inc (1.19M shares), BlackRock Inc. (960K shares), 683 Capital Management, LLC (805K shares), PURA VIDA INVESTMENTS, LLC (571K shares), and MORGENS WATERFALL VINTIADIS & CO INC (375K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.